CORRELATION OF BLOOD PRESSURE VARIABILITY AND MARKERS OF INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS: SYSTEMATIC REVIEW
Main Article Content
Keywords
CKD, Cardiovascular disease, survival, morbidity
Abstract
Background: Cardiovascular complications, including blood pressure variability (BPV) is linked with chronic kidney disease (CKD). Inflammatory markers are known to be elevated in CKD and may play a role in BPV. In this systematic review our aims to study in deep the correlation between BPV and inflammatory markers in patients with CKD.
Methods: Studies published from first month of 2014 to sixth month of 2024 and these studies was indexed in PubMed, Scopus, and Cochrane Library. Researches and reviews which explored the correlation between blood pressure variability and inflammatory markers in chronic kidney disease patients were selected. The data extraction and quality evaluation were carried out separately by two reviewers.
Results: Among the 1375 articles reviewed, 28 had different definitions for BPV and inflammatory markers, but the majority of studies focused on systolic and diastolic BPV. These studies mostly found elevated BPV and higher IL-6 levels. Meta- analysis indicated a combined correlation coefficient of 0.42 (95% CI: 0.30-0.54) between systolic BPV and CRP.
Conclusion: This review reveals a strong positive relationship between BPV and inflammatory markers in CKD patients, suggesting that inflammation could play a role in BPV fluctuations. This emphasizes the requisite for additional research to explore the methods behind this connection and identify possible therapeutic targets.
References
2. Mallamaci, F., & Zoccali, C. (2017). Blood pressure variability in chronic kidney disease patients: The overlooked conundrum. Hypertension, 70(2), 264-266. doi: 10.1161/HYPERTENSIONAHA.117.09352
3. Lee, S. Y., Kim, Y. W., Lee, Y. J., Song, J. H., & Han, S. W. (2021). Association between blood pressure variability and inflammatory markers in chronic kidney disease patients. Kidney Research and Clinical Practice, 40(1), 64-71. doi: 10.23876/j.krcp.20.112
4. Luo, P., Tan, Z., Zhang, Z., Wang, Z., & Liu, H. (2019). Inflammatory markers in chronic kidney disease and cardiovascular disease. Cardiovascular & Hematological Disorders Drug Targets, 19(2), 85-93. doi: 10.2174/1871529X19666191029114220
5. Brueckmann, M., Schulz, S., Wolter, J. S., & Borger, M. (2020). The role of inflammation in chronic kidney disease-associated cardiovascular disease: A narrative review. European Heart Journal, 41(9), 982-988. doi: 10.1093/eurheartj/ehz806
6. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clinical Res ed). 2015;350:g7647.
7. Kotanko, P., Glorieux, G., De Deyn, P. P., & Vanholder, R. (2021). Inflammation and blood pressure variability in CKD: A vicious cycle? Nephrology Dialysis Transplantation, 36(1), 29-35. doi: 10.1093/ndt/gfab071
8. Matsumoto, A., Itoh, H., & Tamura, K. (2021). Blood pressure variability and inflammation in cardiovascular risk management of chronic kidney disease. Journal of Clinical Hypertension, 23(5), 890-897. doi: 10.1111/jch.14230
9. Pickering, T. G., Shimbo, D., & Haas, D. (2006). Ambulatory blood-pressure monitoring.New England Journal of Medicine, 354(22), 2368-2374. doi: 10.1056/NEJMra050802
10. Weiner, D. E., Tighiouart, H., Levey, A. S., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Sarnak, M. J. (2007). Lower levels of estimated glomerular filtration rate and higher levels of albuminuria are associated with increased risk of cardiovascular events in patients with chronic kidney disease. Kidney International, 71(6), 589-596. doi: 10.1038/sj.ki.5002115
11. Foley, R. N., Parfrey, P. S., & Sarnak, M. J. (1998). Clinical epidemiology of cardiovascular disease in chronic renal disease. American Journal of Kidney Diseases, 32(5), S112-S119. doi: 10.1053/ajkd.1998.v32.pm9820470
12. Agarwal, R., & Andersen, M. J. (2005). Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney International, 69(7), 1175-1180. doi: 10.1038/sj.ki.5000144
13. Farmer, C. K., Goldsmith, D. J., Cox, J., & Dallyn, P. E. (1999). Ambulatory blood pressure monitoring in patients with chronic renal failure. Nephrology Dialysis Transplantation, 14(3), 716-721. doi: 10.1093/ndt/14.3.716
14. Agarwal, R. (2009). Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clinical Journal of the American Society of Nephrology, 4(4), 830-837. doi: 10.2215/CJN.05831108
15. Levin, A., Djurdjev, O., Barrett, B., Burgess, E., Carlisle, E. J., Ethier, J., ... & Tobe, S. (2006). Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter. American Journal of Kidney Diseases, 48(3), 337-347. doi: 10.1053/j.ajkd.2006.05.030
16. Kooman, J. P., & Kotanko, P. (2011). Causes and consequences of inflammation in dialysis patients. Journal of Renal Care, 37(1), 14-23. doi: 10.1111/j.1755- 6686.2011.00207.x
17. Carrero, J. J., Stenvinkel, P., Cuppari, L., Ikizler, T. A., Kalantar-Zadeh, K., Kaysen, G., & Kovesdy, C. P. (2018). Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). Journal of Renal Nutrition, 28(2), 137-150. doi: 10.1053/j.jrn.2018.01.008
18. Kalantar-Zadeh, K., Kopple, J. D., Block, G., & Humphreys, M. H. (2001). A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. American Journal of Kidney Diseases, 38(6), 1251- 1263. doi: 10.1053/ajkd.2001.29222
19. Sarafidis, P. A., Li, S., Chen, S. C., Collins, A. J., & Brown, W. W. (2008). Hypertension awareness, treatment, and control in chronic kidney disease. American Journal of Medicine, 121(4), 332-340. doi: 10.1016/j.amjmed.2007.11.025
20. Tripepi, G., Mattace-Raso, F., Mallamaci, F., & Zoccali, C. (2009). Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clinical Journal of the American Society of Nephrology, 4(2), 267-274. doi: 10.2215/CJN.03730708
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Syed Tahseen Raza
Assistant Professor, Department of Physiology, Era’s Lucknow Medical College Hospital, Era University, Lucknow, India 226003
Dr. Seema Singh
Professor and Head, Department of Physiology, Era’s Lucknow Medical College Hospital, Era University, Lucknow, India 226003
Dr. Devendra Kumar
Professor, Department of Medicine, Era’s Lucknow Medical College Hospital, Era University, Lucknow, India 226003
Dr. Sharique Ahmad
Professor, Department of Pathology, Era’s Lucknow Medical College Hospital, Era University, Lucknow, India 226003